Validation of the TAPS-1: A Four-Item Screening Tool to Identify Unhealthy Substance Use in Primary Care

被引:51
作者
Gryczynski, Jan [1 ]
McNeely, Jennifer [2 ]
Wu, Li-Tzy [3 ]
Subramaniam, Geetha A. [4 ]
Svikis, Dace S. [5 ]
Cathers, Lauretta A. [5 ]
Sharma, Gaurav [6 ]
King, Jacqueline [6 ]
Jelstrom, Eve [6 ]
Nordeck, Courtney D. [1 ]
Sharma, Anjalee [1 ]
Mitchell, Shannon G. [1 ]
O'Grady, Kevin E. [7 ]
Schwartz, Robert P. [1 ]
机构
[1] Friends Res Inst, Baltimore, MD 21201 USA
[2] NYU, Sch Med, New York, NY USA
[3] Duke Univ, Sch Med, Durham, NC USA
[4] Natl Inst Drug Abuse, Ctr Clin Trials Network, Bethesda, MD USA
[5] Virginia Commonwealth Univ, Richmond, VA USA
[6] Emmes Corp, Rockville, MD USA
[7] Univ Maryland, College Pk, MD 20742 USA
关键词
unhealthy substance use; substance use disorders; screening; primary care; RANDOMIZED CONTROLLED-TRIAL; ILLICIT DRUG-USE; BRIEF INTERVENTION; GLOBAL BURDEN; USE DISORDERS; TEST ASSIST; ALCOHOL; DEPENDENCE; SMOKING; ABUSE;
D O I
10.1007/s11606-017-4079-x
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The Tobacco, Alcohol, Prescription Medication, and Other Substance use (TAPS) tool is a combined two-part screening and brief assessment developed for adult primary care patients. The tool's first-stage screening component (TAPS-1) consists of four items asking about past 12-month use for four substance categories, with response options of never, less than monthly, monthly, weekly, and daily or almost daily. To validate the TAPS-1 in primary care patients. Participants completed the TAPS tool in self- and interviewer-administered formats, in random order. In this secondary analysis, the TAPS-1 was evaluated against DSM-5 substance use disorder (SUD) criteria to determine optimal cut-points for identifying unhealthy substance use at three severity levels (problem use, mild SUD, and moderate-to-severe SUD). Two thousand adult patients at five primary care sites. DSM-5 SUD criteria were determined via the modified Composite International Diagnostic Interview. Oral fluid was used as a biomarker of recent drug use. Optimal frequency-of-use cut-points on the self-administered TAPS-1 for identifying SUDs were monthly use for tobacco and alcohol (sensitivity = 0.92 and 0.71, specificity = 0.80 and 0.85, AUC = 0.86 and 0.78, respectively) and any reported use for illicit drugs and prescription medication misuse (sensitivity = 0.93 and 0.89, specificity = 0.85 and 0.91, AUC = 0.89 and 0.90, respectively). The performance of the interviewer-administered format was similar. When administered first, the self-administered format yielded higher disclosure rates for past 12-month alcohol use, illicit drug use, and prescription medication misuse. Frequency of use alone did not provide sufficient information to discriminate between gradations of substance use problem severity. Among those who denied drug use on the TAPS-1, less than 4% had a drug-positive biomarker. The TAPS-1 can identify unhealthy substance use in primary care patients with a high level of accuracy, and may have utility in primary care for rapid triage.
引用
收藏
页码:990 / 996
页数:7
相关论文
共 32 条
[1]  
Adhikari B., 2008, Morbidity and Mortality Weekly Report, V57, P1226
[2]   Ultra-rapid screening for substance-use disorders: The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST-Lite) [J].
Ali, Robert ;
Meena, Sonali ;
Eastwood, Brian ;
Richards, Ian ;
Marsden, John .
DRUG AND ALCOHOL DEPENDENCE, 2013, 132 (1-2) :352-361
[3]  
[Anonymous], FIN REC STAT TOB SMO
[4]  
[Anonymous], 2013, DIAGNOSTIC STAT MANU, VFifth, P1000, DOI DOI 10.1176/APPI.BOOKS.9780890425596
[5]   Validation of PHQ-2 and PHQ-9 to Screen for Major Depression in the Primary Care Population [J].
Arroll, Bruce ;
Goodyear-Smith, Felicity ;
Crengle, Susan ;
Gunn, Jane ;
Kerse, Ngaire ;
Fishman, Tana ;
Falloon, Karen ;
Hatcher, Simon .
ANNALS OF FAMILY MEDICINE, 2010, 8 (04) :348-353
[6]   Brief motivational intervention at a clinic visit reduces cocaine and heroin use [J].
Bernstein, J ;
Bernstein, E ;
Tassiopoulos, K ;
Heeren, T ;
Levenson, S ;
Hingson, R .
DRUG AND ALCOHOL DEPENDENCE, 2005, 77 (01) :49-59
[7]   Societal Costs of Prescription Opioid Abuse, Dependence, and Misuse in the United States [J].
Birnbaum, Howard G. ;
White, Alan G. ;
Schiller, Matt ;
Waldman, Tracy ;
Cleveland, Jody M. ;
Roland, Carl L. .
PAIN MEDICINE, 2011, 12 (04) :657-667
[8]   Oral Fluid Testing for Drugs of Abuse [J].
Bosker, Wendy M. ;
Huestis, Marilyn A. .
CLINICAL CHEMISTRY, 2009, 55 (11) :1910-1931
[9]   The Looming Expansion And Transformation Of Public Substance Abuse Treatment Under The Affordable Care Act [J].
Buck, Jeffrey A. .
HEALTH AFFAIRS, 2011, 30 (08) :1402-1410
[10]   The Effect of Computer-Mediated Administration on Self-Disclosure of Problems on the Addiction Severity Index [J].
Butler, Stephen F. ;
Villapiano, Albert ;
Malinow, Andrew .
JOURNAL OF ADDICTION MEDICINE, 2009, 3 (04) :194-203